Document

Full-Service CRO Excellence

End-to-End Solutions, from early-phase trials to post-marketing studies. Partner with us for comprehensive solutions that drive your success.

View Our Capabilities

Scientific Proficiency at the Core of Trials

Empowering Innovation and Advancing Vital Therapies Across Diverse Therapeutic Areas, with Extensive Experience Supporting 290+ Clinical Trials across 15+ Therapeutic Domains.

Therapeutic Expertise

Transcending Global Boundaries

With locations across the globe, we facilitate global trials with a localized touch, reducing time-to-market and ensuring broad accessibility.

Our Global Footprint

Full-service CRO Therapeutic Expertise Global Reach Regulatory Excellence

Shaping the Future Of Biotech

Know More

Offering decades of clinical research expertise, global compliance, and therapeutic experience to ensure your promising therapy isn’t delayed by risk or limited resources.
Full-service Excellence in Clinical Research

View our Capabilities

End-to-end solutions, from early-phase trials to post-marketing studies. Partner with us for comprehensive solutions that drive your success.
Scientific Proficiency at the Core of Trials

Therapeutic Expertise

Empowering Innovation and Advancing Vital Therapies Across Diverse Therapeutic Areas, with Extensive Experience Supporting Over 275+ Clinical Trials across 15+ Therapeutic Domains.
Transcending Global Boundaries

Our Global Footprint

With locations across the globe, we facilitate global trials with a localized touch, reducing time-to-market and ensuring broad accessibility.
Paving the Path to Regulatory Success

Learn More

Honored with CPHI Pharma Awards 2023 for Regulatory Excellence, we expertly navigate the Regulatory landscape, for Swift Approvals and Compliance, leveraging our proven track record.

Capabilities

Comprehensive CRO capabilities spanning early to late-phase clinical development, supported by global operations, scientific expertise, and regulatory alignment.

Therapeutic Excellence

Advancing vital therapies across diverse therapeutic areas

Accelerating Biosimilar Development

Lambda holds a strong legacy in biosimilar development, covering a broad portfolio of molecules such as Adalimumab, Bevacizumab, Denosumab, Pertuzumab, Rituximab, Daratumumab, Trastuzumab, Trastuzumab Emtansine, Vedolizumab, Ranibizumab, Teriparatide, Aflibercept, Filgrastim, and Pegfilgrastim.

End-to-End Solutions

Full-service CRO Capabilities

Analytical Excellence

State-of-the-art lab with ELISA, ECLIA, IVD, Flow Cytometry and More

Accelerating Biosimilar Development

Lambda holds a strong legacy in biosimilar development, covering a broad portfolio of molecules such as Adalimumab, Bevacizumab, Denosumab, Pertuzumab, Rituximab, Daratumumab, Trastuzumab, Trastuzumab Emtansine, Vedolizumab, Ranibizumab, Aflibercept, Teriparatide, Filgrastim, and Pegfilgrastim.

End-to-End Solutions

Full-service offerings from Preclinical to Regulatory Support

Analytical Excellence

State-of-the-art lab with ELISA, ECLIA, IVD, Flow Cytometry & More

Why Lambda?

We bring together integrated capabilities and global operations to support biotech and pharmaceutical companies across clinical development and resource support needs.

A Global CRO with Operations across Continents

Full-Spectrum Clinical Research Services

Strong Credit Rating in the CRO Industry

Experienced Leadership team with Strong Industry Expertise

A Truly Global CRO with Multi-continental Presence

Comprehensive Clinical Research Services

Best Credit rating in CRO Industry

Strong Leadership with 20+ years of Experience

PK/PD Studies

0 +

Late-Phase Trials

0 +

Validated Assays

0 +

Professionals

0 +

‘Regulatory & Compliance Excellence Award’ at the CPHI Pharma Awards 2023 for the exceptional work by Lambda in ‘Enhancing Compliance & Data Generation in Clinical Trials through Advanced Software Solutions and EDC Platform.’